As of 26 Aug 2024, GlaxoSmithKline Pharmaceuticals total assets is $396.90M, an decrease of -28.20% to 2022. This figure includes all the resources and properties owned by GlaxoSmithKline Pharmaceuticals, reflecting its financial standing at that time.
Year | Total Assets | Change |
---|---|---|
2023 | $396.90M | -28.20% |
2022 | $552.80M | 48.76% |
2021 | $371.61M | -0.67% |
2020 | $374.11M | -19.83% |
2019 | $466.67M | - |